Brazil, Morocco may need to wait more for desi jabs
Countries like Brazil and Morocco may need to wait a few days more for “made-in-India” Covid-19 vaccines as India sharpens its vaccine diplomacy to derive geopolitical and strategic gains.

Countries like Brazil and Morocco may need to wait a few days more for “made-in-India” Covid-19 vaccines as India sharpens its vaccine diplomacy to derive geopolitical and strategic gains.
Serum Institute of India (SII) will dispatch its first overseas consignment of 20 lakh doses of the Covishield vaccine to Brazil two weeks from now, chief executive officer (CEO) Adar Poonawalla said on Friday.
India and China are, quite unwittingly, on opposing sides of a heated political contest in Brazil, one involving Covishield by the Serum Institute and Coronavac by China’s Sinovac.
The government on Tuesday clarified there was no export ban on the approved vaccines with both Serum Institute of India (SII) and Bharat Biotech, the producers of Covishield and Covaxin, respectively issuing a joint statement saying vaccines are global public goods and they would stand by their commitment to supply vaccines globally.
Brazil's leader Jair Bolsonaro is moving to assert control of the nation's independent health regulator, Anvisa, a move some health experts fear will politicize the agency and give the president, one of the world's most prominent coronavirus skeptics, free rein over vaccine approvals.
Brazil is just the second country to surpass a death toll of 120,000 in the pandemic, after the United States, where the number killed is now more than 182,000. Unlike in Europe and Asia, where the virus hit hard and then subsided, Brazil's outbreak is advancing at a slow but devastating pace.
Brazil's Acting Health Minister General Eduardo Pazuello said the vaccine could be available for Brazilians by December or January.
Brazilian President Jair Bolsonaro issued a decree on Thursday to provide 1.9 billion reais ($356 million) in funds to purchase and eventually produce a COVID-19 vaccine being developed by AstraZeneca PLC and Oxford University researchers.
Brazil will face another "one or two more months of economic difficulties" as a result of the impact caused by the pandemic, Xinhua news agency quoted Guedes as saying on Wednesday.
If Brazil's underfunded medical institutions are unable to meet their ambitious goals, it would mark the latest failure by President Jair Bolsonaro's government to control the virus. It would also leave Brazil vulnerable to a frenzied global scramble for vaccine supplies.
Just days after her husband said he had overcome the virus with a negative test following weeks in quarantine, Bolsonaro's wife Michelle has tested positive, the presidential office said in a statement.